文献速递糖尿病

血红蛋白A1c遗传变异与遗传推断为非裔美国人/非裔英国人和欧洲血统人群的糖尿病视网膜病变风险差异

Hemoglobin A1c Genetics and Disparities in Risk of Diabetic Retinopathy in Individuals of Genetically Inferred African American/African British and European Ancestries.
PubMed 文献 · Diabetes Care · 2024-01-01

研究利用29,828例遗传推断为非裔美国人/非裔英国人和欧洲血统的2型糖尿病病例,计算由122个与HbA1c全基因组显著相关但与血糖无关的变异构成的非血糖性HbA1c多基因评分(ngA1cPS),并检测其及G6PD变异(rs1050828)与视网膜病变的关联。结果显示,ngA1cPS最低五分位者视网膜病变患病率较该五分位以上者高20%至50%,尽管实测HbA1c水平相近;校正后荟萃分析比值比在非洲血统为1.31(95%CI 1.0, 1.73;P=0.05),欧洲血统为1.31(95%CI 1.15, 1.50;P=6.5×10-5)。作者认为需考虑遗传效应以个体化HbA1c目标并改善不同血统糖尿病患者的结局。

要点

  • ngA1cPS最低五分位者视网膜病变患病率比该五分位以上者高20%至50%,尽管实测HbA1c相近。
  • 校正后视网膜病变比值比:非洲血统1.31(95%CI 1.0, 1.73;P=0.05),欧洲血统1.31(95%CI 1.15, 1.50;P=6.5×10-5)。
  • 非洲血统且HbA1c低于7%者中,ngA1cPS低于第50百分位者视网膜病变患病率高于高于第50百分位者,与性别或G6PD携带状态无关。

核心结论

  • 降低HbA1c的非血糖性遗传变异及G6PD变异(rs1050828)与更高的视网膜病变风险相关。
  • 作者认为需考虑遗传效应以个体化HbA1c目标并改善不同血统糖尿病患者的结局。

研究设计与样本

  • 研究纳入29,828例遗传推断为非裔美国人/非裔英国人和欧洲血统的2型糖尿病病例。
  • 计算由122个与HbA1c全基因组显著相关但与血糖无关的变异构成的血统特异性非血糖性HbA1c多基因评分(ngA1cPS)。
  • 检测ngA1cPS和G6PD变异(rs1050828)与视网膜病变的关联,并校正实测HbA1c及视网膜病变危险因素。

主要发现

  • ngA1cPS最低五分位者视网膜病变患病率比该五分位以上者高20%至50%,尽管实测HbA1c水平相近。
  • 校正后荟萃分析视网膜病变比值比:非洲血统1.31(95%CI 1.0, 1.73;P=0.05),欧洲血统1.31(95%CI 1.15, 1.50;P=6.5×10-5)。
  • 非洲血统且HbA1c低于7%者中,ngA1cPS低于第50百分位者视网膜病变患病率高于高于第50百分位者,与性别或G6PD携带状态无关。

临床怎么用

  • 作者认为需考虑遗传效应以个体化HbA1c目标并改善不同血统糖尿病患者的结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Individuals with diabetes who carry genetic variants that lower hemoglobin A1c (HbA1c) independently of glycemia may have higher real, but undetected, hyperglycemia compared with those without these variants despite achieving similar HbA1c targets, potentially placing them at greater risk for diabetes-related complications. We sought to determine whether these genetic variants, aggregated in a polygenic score, and the large-effect African ancestry-specific missense variant in G6PD (rs1050828) that lower HbA1c were associated with higher retinopathy risk. RESEARCH DESIGN AND METHODS: Using data from 29,828 type 2 diabetes cases of genetically inferred African American/African British and European ancestries, we calculated ancestry-specific nonglycemic HbA1c polygenic scores (ngA1cPS) composed of 122 variants associated with HbA1c at genome-wide significance, but not with glucose. We tested the association of the ngA1cPS and the G6PD variant with retinopathy, adjusting for measured HbA1c and retinopathy risk factors. RESULTS: Participants in the bottom quintile of the ngA1cPS showed between 20% and 50% higher retinopathy prevalence, compared with those above this quintile, despite similar levels of measured HbA1c. The adjusted meta-analytic odds ratio for the bottom quintile was 1.31 (95% CI 1.0, 1.73; P = 0.05) in African ancestry and 1.31 (95% CI 1.15, 1.50; P = 6.5 × 10-5) in European ancestry. Among individuals of African ancestry with HbA1c below 7%, retinopathy prevalence was higher in individuals below, compared with above, the 50th percentile of the ngA1cPS regardless of sex or G6PD carrier status. CONCLUSIONS: Genetic effects need to be considered to personalize HbA1c targets and improve outcomes of people with diabetes from diverse ancestries.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mandla R, Schroeder PH, Florez JC, et al. Hemoglobin A1c Genetics and Disparities in Risk of Diabetic Retinopathy in Individuals of Genetically Inferred African American/African British and European Ancestries. Diabetes Care. 2024. PMID: 39042486. doi:10.2337/dc23-1691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。